The Access to COVID-19 Tools ACT-Accelerator, is a new, groundbreaking global collaboration to accelerate the development, production, and equitable access to COVID-19 diagnostics, therapeutics, and vaccines.
It was set up in response to a call from G20 leaders in March and launched by the WHO, EC, France and The Bill & Melinda Gates Foundation in April 2020.
4673
ACT-Accelerator不是一个决策机构或新设的组织。
The ACT-Accelerator is not a decision-making body or a new organization, but works to speed up collaborative efforts among existing organizations to end the pandemic.
4674
它致力于加快现有组织之间的协作，以结束这场大流行。
It is a framework for collaboration that has been designed to bring key players around the table with the goal of ending the pandemic as quickly as possible by reducing COVID-19 mortality and severe disease through the accelerated development, equitable allocation, and scaled up delivery of vaccines, therapeutics and diagnostics, thereby protecting health systems and restoring societies and economies in the near term.
It draws on the experience of leading global health organizations which are tackling the world’s toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19.
Its members share a commitment to ensure all people have access to all the tools needed to defeat COVID-19 and to work with unprecedented levels of partnership to achieve it.
4677
ACT-Accelerator的四个工作领域是：诊断工具，治疗方法，疫苗，卫生系统连接。
The ACT-Accelerator has four areas of work: diagnostics, therapeutics, vaccines and the health system connector.
4678
获取和分配是贯穿所有这些领域的主线。
Cross-cutting all of these is the workstream on Access & Allocation.
4679
全球科学界联合起来跟踪COVID-19研发进展，确定新的研究重点和关键差距所在
Global scientific community unites to track progress on COVID-19 R&D, identifies new research priorities and critical gaps